Your browser doesn't support javascript.
loading
Correction to: Pristimerin induces apoptosis in imatinib-resistant chronic myelogenous leukemia cells harboring T315I mutation by blocking NF-κB signaling and depleting Bcr-Abl.
Lu, Zhongzheng; Jin, Yanli; Chen, Chun; Li, Juan; Cao, Qi; Pan, Jingxuan.
Affiliation
  • Lu Z; Department of Pathophysiology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, PR China.
  • Jin Y; Department of Pathophysiology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, PR China.
  • Chen C; Department of Pediatrics, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, PR China.
  • Li J; Department of Hematology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, PR China.
  • Cao Q; Department of Pathophysiology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, PR China.
  • Pan J; Department of Pathophysiology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, PR China. panjx2@mail.sysu.edu.cn.
Mol Cancer ; 20(1): 172, 2021 Dec 31.
Article in En | MEDLINE | ID: mdl-34969396
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Mol Cancer Journal subject: NEOPLASIAS Year: 2021 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Mol Cancer Journal subject: NEOPLASIAS Year: 2021 Document type: Article